<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Diabetes Mellitus in Children</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

      <h1>Diabetes Mellitus in Children</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <!-- READ SUMMARY CONTAINER -->
        
              <!-- Summary Overlay -->
              <div class="summary-overlay" id="summaryOverlay"></div>
        
        
              <div class="summary-card" id="summaryCard">
                
                <div class="summary-header">
                  <h3>Note Summary</h3>
                  <div class="icon-box">
                    <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                    <img src="../images/icons/summary.png" alt="Icon" class="icon">
                  </div>
                </div>
                <div class="summary-content">
                  <!-- Summary content goes here -->
                  <p><i>This content is not available yet.</i></p>
        
                  <span class="close-btn" id="closeBtn">close</span>
                </div>
              </div>
        
              <div class="summary-trigger" id="summaryTrigger">
                <p>Click here to read a summary</p>
            </div>
        <!-- END OF READ SUMMARY CONTAINER -->
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>DM</strong> can be defined as a chronic metabolic disorder of multiple aetiologies characterized by chronic <strong>hyperglycemia</strong> with disturbances of <strong>CHO</strong>, <strong>fat</strong>, & <strong>protein</strong> metabolism resulting from defects in <strong>insulin</strong> secretion, action, or both.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Classification</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>Type 1</strong> - neonatal transient, neonatal permanent, & autoimmune</li>
            <li><strong>Type 2</strong> ‚Äì classically associated with <strong>obesity</strong>, <strong>MODY</strong> (genetic, types 1-6)</li>
            <li><strong>Secondary Forms</strong> (cystic fibrosis, haemochromatosis, <strong>Cushing's syndrome</strong>, <strong>acromegaly</strong>, <strong>phaeochromatoma</strong>, <strong>hyperthyroidism</strong>)</li>
          </ul>
          

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Transient Diabetes Mellitus of the Newborn</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>TDM</strong> in the newborn has onset in 1st weeks of life.</li>
            <li>Persists several weeks to months.</li>
            <li>Occurs most often in <strong>SGA</strong>.</li>
            <li>Low/absent <strong>insulin</strong> response to glucose.</li>
            <li>Characterized by <strong>hyperglycemia</strong>, <strong>glycosuria</strong> ‚Üí severe dehydration ¬± metabolic acidosis.</li>
            <li>Minimal or no <strong>ketonemia</strong> or <strong>ketonuria</strong>.</li>
            <li><strong>Insulin</strong> is mandatory during active phase. (1-2U/kg/day in 2 doses).</li>
            <li>Resolves spontaneously.</li>
            <li>Improvement, accelerated growth & weight gain.</li>
            <li><strong>Prognosis</strong> ‚Äì Excellent.</li>
            <li>DD- <strong>pancreatic agenesis</strong>.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Type 2 DM</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>Previously known as <strong>Adult-onset</strong>, <strong>NIDDM</strong>, <strong>MODY</strong>.</li>
            <li><strong>Increase</strong> incidence because of <strong>increase</strong> childhood obesity.</li>
            <li>Not <strong>Insulin-Dependent</strong> (except during stress, etc., for symptomatic hyperglycemia).</li>
            <li>Not ketosis-prone (severe infections, stress).</li>
            <li>Insidious presentation usually - (routine medical exam or for other problems).</li>
            <li>Minority of all DM patients in pediatric years (10-20%).</li>
            <li>Inherited nature ‚Äì stronger than T1DM, <strong>polygenic</strong> but strong family history.</li>
            <li>No known <strong>HLA</strong> or association with autoimmune markers or diagnosis.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Maturity Onset Diabetes of the Young</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>Uncommon but distinct entity.</li>
            <li>Presentation < 25 years, often teenager.</li>
            <li>Probably A-D without skipping.</li>
            <li>Associated with mutations of <strong>glucokinase</strong> gene in chromosome 7.</li>
          </ul>
          
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Type 1 DM</a>
          </h2>
        </header>
        <div class='body'>

          <section id='heading-6-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-1'>Epidemiology</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li>Accounts for <strong>more than 90%</strong> of Childhood & Adolescent DM.</li>
                <li><strong>100,000</strong> children < 15 years develop T1DM annually with wide global variations in incidence.</li>
                <li><strong>Finland</strong> (highest), <strong>Korea</strong> (low), few data from Africa.</li>
                <li>Seasonal onset - <strong>winter</strong>.</li>
                <li>Can manifest at any age (approximately <strong>50%</strong> at > 18 years).</li>
                <li>Bimodal peak age distribution: <strong>5-7 years</strong> & <strong>puberty</strong>.</li>
                <li>No sex predilection.</li>
                <li><strong>Autoimmune</strong> antibodies in > 90% of patients, associated with thyroiditis.</li>
              </ul>
              

            </div>
          </section>

          <section id='heading-6-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-2'>Risk Factors</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li>Chronic <strong>autoimmune</strong> disease ‚Äì vast majority (<strong>HLA DR3 & 4</strong>, <strong>B8, BW15</strong> on chr 6).</li>
                <li>T-cell mediated autoimmune destruction of pancreatic Œ≤-cells in genetically predisposed individuals. (<strong>Islet AB</strong>, <strong>Insulin AB</strong>).</li>
                <li>Idiopathic ‚Äì few.</li>
                <li>Seasonal factors - new cases more common in <strong>winter/autumn</strong>.</li>
                <li>No evidence yet with commercial infant formula that contains cow‚Äôs milk protein.</li>
              </ul>
              

            </div>
          </section>

          <section id='heading-6-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-3'>Pathophysiology</a>
              </h3>
            </header>
            <div class='body'>
                          <!-- image here -->
            <div class="image-container">
              <img src="../figures/diabetes-mellitus-in-chidren (1).png" alt="" onclick="openModal(this)">
              <div class="caption">Pathophysiology</div>
            </div>
            
            <div id="myModal" class="modal">
              <span class="close" onclick="closeModal()">&times;</span>
              <img class="modal-content" id="modalImage">
              <div id="caption" class="caption">Pathophysiology</div>
            </div>

            <ul>
              <li><strong>Insulinopenia</strong> ‚Üí <strong>decreased</strong> glucose utilization (muscle, fat).</li>
              <li>‚Üí postprandial hyperglycemia, at lower insulin levels ‚Üí <strong>increased</strong> hepatic glycogenolysis/gluconeogenesis ‚Üí fasting hyperglycemia ‚Üí osmotic diuresis.</li>
              <li>‚Üí glucosuria ‚Üí calorie & energy loss ‚Üí dehydration.</li>
            </ul>
            
                        <!-- image here -->
                        <div class="image-container">
                          <img src="../figures/diabetes-mellitus-in-chidren (2).png" alt="" onclick="openModal(this)">
                          <div class="caption">Pathophysiology</div>
                        </div>
                        
                        <div id="myModal" class="modal">
                          <span class="close" onclick="closeModal()">&times;</span>
                          <img class="modal-content" id="modalImage">
                          <div id="caption" class="caption">Pathophysiology</div>
                        </div>

            </div>
          </section>

          <section id='heading-6-4'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-4'>Clinical Manifestations</a>
              </h3>
            </header>
            <div class='body'>
              <p>Symptoms develop when about 90% of Œ≤ cells are destroyed:</p>
              <ul>
                <li>Polyuria, nocturia,</li>
                <li>Bedwetting,</li>
                <li>Excessive thirst,</li>
                <li>Weight loss,</li>
                <li>Fatigue,</li>
                <li>Polyphagia or depressed appetite,</li>
                <li>Persistent mycotic infection.</li>
              </ul>
              <p>Ketosis ¬± Acidosis:</p>
              <ul>
                <li>Abdominal pain,</li>
                <li>Nausea, vomiting,</li>
                <li>Tachypnea and deep respiration,</li>
                <li>‚ÄúKetone smell‚Äù,</li>
                <li>Lethargy, obtundation, coma.</li>
              </ul>
              <p>Asymptomatic:</p>
              <ul>
                <li>Fortuitous discovery of glycosuria (beware of renal diabetes).</li>
              </ul>
              

            </div>
          </section>

          <section id='heading-6-5'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-5'>Diagnosis of Diabetes - ADA Expert Committee</a>
              </h3>
            </header>
            <div class='body'>
              <br>

              <table class="note-table">
                <tr>
                  <th></th>
                  <th>NORMAL</th>
                  <th>IMPAIRED</th>
                  <th>DIABETES</th>
                </tr>
                <tr>
                  <td>FASTING</td>
                  <td>&lt; 100 mg%<br>(5.5mmol/L)</td>
                  <td>100-125</td>
                  <td>&ge; 126 mg%<br>(7mmol/L)</td>
                </tr>
                <tr>
                  <td>ORAL GTT<br>(2 hours)</td>
                  <td>&lt; 140 mg%<br>(7.8mmol/L)</td>
                  <td>140-199</td>
                  <td>&ge; 200 mg%<br>(11.1mmol/L)</td>
                </tr>
              </table>
              

            </div>
          </section>

          <section id='heading-6-6'>
            <header>
              <h3>
                <a aria-hidden href='#heading-6-6'>Diabetic Ketoacidosis (DKA)</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li>Stage of severe metabolic decompensation as a result of severe deficiency of insulin or its effectiveness.</li>
                <li>Most serious metabolic disturbance of T1DM.</li>
                <li>DKA & its complications ‚Äì Most common cause of morbidity and mortality in individuals with T1DM.</li>
                <li>Manifestations:</li>
                <ul>
                  <li>Hyperglycemia ‚Äì BG &gt; 200mg% (11.1mmol/l).</li>
                  <li>Metabolic acidosis from overproduction of ketone acids. pH &lt; 7.30, plasma HCO3 &lt; 15mEq/l.</li>
                </ul>
              </ul>
              

              <section id='heading-6-6-1'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-6-6-1'>DKA: Lab Features</a>
                  </h4>
                </header>
                <div class='body'>
                  <ul>
                    <li>Ketonuria</li>
                    <li>Ketoacidosis</li>
                    <li>Increased anion gap</li>
                    <li>Decreased Serum HCO3, pH</li>
                    <li>Increased serum osmolality</li>
                    <li>Hypertonic dehydration</li>
                  </ul>
        
                </div>
              </section>

              <section id='heading-6-6-2'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-6-6-2'>Risk Factors for DKA</a>
                  </h4>
                </header>
                <div class='body'>
                  <ul>
                    <li>Young age &lt; 5 years, lower socioeconomic status</li>
                    <li>In established T1D: Higher Hb A1C</li>
                    <li>Adolescents (especially females)</li>
                    <li>Infections, longer duration</li>
                    <li>Psychiatric disorders</li>
                    <li>Precipitating factors: poor metabolic control & frequently missed insulin injections, infections, trauma, psychological & emotional stress especially in adolescents</li>
                  </ul>
        
                </div>
              </section>



              <section id='heading-6-6-3'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-6-6-3'>DKA: Pathogenesis</a>
                  </h4>
                </header>
                <div class='body'>
                  <ul>
                    <li><strong>Increased counter regulatory hormones</strong> ‚Üí Glycogenolysis & gluconeogenesis BG &gt; 250mg/dl  &gt; renal threshold ‚Üí glycosuria ‚Üí osmotic diuresis + decreased intake & vomiting ‚Üí dehydration (decreased GFR) ‚Üí  increased BG  ‚Üí electrolyte disturbance (activation of RAS-aldosterone axis ‚Üí serum K+ loss ‚Üí risk of C.Oedema).</li>
                    <li><strong>Increased catabolism & cellular loss</strong> ‚Üí loss of Na, K, PO4.</li>
                    <li>Formation of buffers ‚Üí depletion of buffers ‚Üí metabolic acidosis.</li>
                  </ul>
                  
        
                </div>
              </section>

              <section id='heading-6-6-4'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-6-6-4'>DKA: Management</a>
                  </h4>
                </header>
                <div class='body'>
                  <ul>
                    <li><strong>Rehydration:</strong> Initial fluid is normal saline.</li>
                    <ul>
                      <li>If in shock, give 30ml/kg over 1-2hrs.</li>
                      <li>Calculate deficit and replace over 48hrs.</li>
                    </ul>
                    <li><strong>Insulin:</strong> Regular insulin 0.05units/kg/hr as continuous infusion (infusion pump or soluset).</li>
                    <li><strong>Potassium:</strong> Add to IVF once urine output is adequate.</li>
                    <li>Determine & treat precipitating factors e.g. fever - blood culture, urine mcs; Avoid urethral catheter - condom drainage of urine.</li>
                    <li><strong>Rehydration phase:</strong> (deficit: Minimal - 30-50mls/kg, Moderate - 50-90mls/kg, Severe - 100mls/kg. Give - 50% in 12hrs, rest in 24hrs, use infusion pump.</li>
                    <li><strong>Maintenance:</strong> 100mls/kg, 1st 10kg, 50ml/kg - 11-20kg, 20ml/kg - &gt;20kg OR 1.5-2 L/m2/day. 10% for fever/hyperventilation. </li>
                  </ul>
                  
                  <h4>Electrolytes in DKA</h4>
                  <ul>
                    <li>K loss - 6-7 mEq/kg. Urinary loss + increased Aldosterone secondary to dehydration.</li>
                    <li>Serum K may be normal or increased because of shift to extracellular space, BUT total body K - depleted, serum K - unreliable. Insulin & fluids will also lower K. Give K as long as IVF.</li>
                    <li>Replace after initial fluid bolus & child making urine.</li>
                    <li>Options: KCL - hyperchloremic acidosis (worsens acidosis), K acetate - metabolized in liver to HCO3.</li>
                    <li>KPO4 - if PO4 low (contributes to buffer) but risk of decrease of Ca & Mg; thus use ‚â§ 1.5mEq/kg/day. Use KPO4 + K acetate.</li>
                  </ul>
                  
                  <h4>Others</h4>
                  <ul>
                    <li><strong>Monitoring:</strong></li>
                    <ul>
                      <li>Hourly serum glucose</li>
                      <li>Serum Na, K, PO4, HCO3, Cl, urea, creatinine, calcium, pH, ketones</li>
                      <li>Urinalysis; ketones, glucose</li>
                      <li>Neurological signs for cerebral edema</li>
                    </ul>
                  </ul>
                  
                </div>
              </section>

              <section id='heading-6-6-5'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-6-6-5'>Complications</a>
                  </h4>
                </header>
                <div class='body'>
                  <ul>
                    <li>Mortality in DKA ‚Äì 0.15-0.31% (UK, North America)</li>
                    <li>Cerebral edema ‚Äì 60-90% of deaths - leading cause</li>
                    <li>Other causes of death - aspiration pneumonia (NGT if vomiting or unconscious), Multi-organ failure</li>
                    <li>Occasionally cerebral thrombosis, infarct, hemorrhage</li>
                    <li>Hypoglycemia, congestive heart failure</li>
                    <li>Renal failure</li>
                  </ul>
                  
                  <h4>Cerebral Edema</h4>
                  <ul>
                    <li>Complication of DKA & its treatment</li>
                    <li>Occurs primarily in children</li>
                    <li>Incidence of clinically significant cerebral edema ‚Äì low (1-2%)</li>
                    <li>No single etiology ‚Äì rapid shift in extracellular fluid (ECF) & intracellular fluid (ICF) osmolality, CNS acidosis, Excess fluid administration, cerebral hypoxia. Final step - through cytokines</li>
                  </ul>
                  
                  <h4>Risk factors of cerebral edema</h4>
                  <ul>
                    <li>Younger children (below 5 years use 0.05 units/kg/h of insulin)</li>
                    <li>Children with newly diagnosed T1DM</li>
                    <li>Failure of Na to rise as predicted</li>
                    <li>Use of bicarbonate therapy</li>
                    <li>A greater degree of acidosis and hypovolemia</li>
                  </ul>
                  
                  <h4>Signs & Treatment of Cerebral Edema</h4>
                  <ul>
                    <li>Usually 4 to 12 hours after initiation of therapy</li>
                    <li>Headache, decreased consciousness, Hypertension, bradycardia, pupil abnormalities, papilloedema, decorticate posturing</li>
                    <li>Reduce rate of fluid administration and give mannitol (1 g/kg iv over 20 min)</li>
                  </ul>
                  

                  <h4>Outpatient Management</h4>
                  <ul>
                    <li><strong>Insulin:</strong> T1DM depend on insulin to live.</li>
                    <li><strong>Nutrition:</strong> Require CHO, protein & fat to grow.</li>
                    <li><strong>Exercise</strong></li>
                    <li><strong>Psychological support:</strong> Child and family.</li>
                    <li><strong>Blood sugar monitoring & HbA1C</strong></li>
                  </ul>
                  
                </div>
              </section>
            </div>
          </section>

        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Management </a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li><strong>Dreadful disease</strong>, requires team support: <strong>paediatrician</strong>, <strong>nurse educator</strong>, <strong>dietician</strong>, <strong>mental health professional</strong>, <strong>social worker</strong>, <strong>peer discussion group</strong>, <strong>summer camps</strong>, <strong>role models</strong>, <strong>support groups</strong></li>
            <li><strong>Aims of therapy</strong>:</li>
            <ul>
              <li>Provide <strong>normal growth</strong>, <strong>puberty</strong>, <strong>psychomotor development</strong>, & <strong>well-being</strong></li>
              <li><strong>Exercise</strong> is an integral component of growth & dev. No sport is excluded.</li>
              <li><strong>Nutrition</strong> - one of cornerstone of mx</li>
              <li>No sp nutrition required other than for <strong>optimal growth & dev</strong>. Same food type as for gen populatn</li>
              <li>Regular eating pattern for <strong>Insulin regimen</strong></li>
              <li>Individual nutritional reqment & meal plan based on <strong>age</strong>, <strong>sex</strong>, <strong>wt</strong>, <strong>activity</strong>, preferences</li>
              <li>Meal plan: <strong>50% CHO</strong>- <strong>70%</strong> as <strong>Complex</strong> eg <strong>starch</strong> to prolong digestion & absorption for slow rise of BG</li>
              <li>Avoid <strong>refined sugars</strong>, give high fiber diet eg <strong>veg</strong>, <strong>legumes</strong>, <strong>whole-meal bread</strong>, <strong>cereals</strong> diet & <strong>sugar-free carbonated drinks</strong>,</li>
              <li><strong>Lipids</strong>-<strong>30%</strong>- limit <strong>cholesterol</strong></li>
              <li><strong>20% protein</strong> (<strong>plant</strong>)- limit <strong>egg-yolk</strong>, give <strong>fish</strong>, <strong>poultry</strong>, <strong>lean-cut meat</strong></li>
              <li>Variable daytime fractioning adapted to <strong>insulin regimen</strong>, <strong>age</strong> phy activity, life-style etc</li>
              <li><strong>3 meals</strong>, <strong>2 snacks</strong>. Night tx snack essential to avoid nocturnal hypoglycemia</li>
              <li>BG target: <strong>fasting/preprandial</strong> ‚Äì <strong>70-130mg/dl</strong></li>
              <li>After meals &lt; <strong>180mg/dl</strong></li>
              <li>Night: not &lt; <strong>60mg/dl</strong> (early morning headache- suggestive of hypoglycemia in the night)</li>
              <li>Standardized <strong>Hb A1c</strong> &lt; <strong>7.7%</strong>; <strong>6-9-good metab control</strong>, <strong>9-12-fair</strong>, &gt; <strong>12 poor</strong></li>
              <li>Avoid severe or frequent hypoglycemia especially- &lt; <strong>5 years</strong> ( <strong>HbA1c</strong> objectives are higher: &gt; <strong>7.5 & &lt; 8.5%</strong>; <strong>BG</strong>: <strong>100- 200mg/dl</strong>)</li>
              <li><strong>Hb A1c</strong>- <strong>glycosylated Hb</strong> -A reliable index of long-term glycemic control</li>
              <li>Represents fraction of Hb to which glucose has been non-enzymatically & irreversibly bound. Occurs throughout the life-span of RBC (3/12)</li>
              <li>Allows estimation & duration of hypoglycemia & initial value to compare treatment</li>
              <li><strong>Hb A1c</strong> is affected by RBC survival eg <strong>haemoglobinopathy</strong></li>
              <li>Recurrent hypoglycaemia-depresses overall average</li>
              <li>For such cases use <strong>fructosamine assay</strong>- non-covalent glycation of serum proteins over 2 weeks</li>
            </ul>
          </ul>

          <section id='heading-7-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-7-1'>Serial Blood Glucose Monitoring</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li>Ideally - <strong>4 times</strong>: before breakfast, lunch, supper & bedtime & if symptoms are present.</li>
                <li>Many types of <strong>glucometer</strong> for home use. Some can store data with time & date.</li>
                <li>Detect <strong>factitious glucose log books</strong>.</li>
              </ul>
              

            </div>
          </section>

          <section id='heading-7-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-7-2'>Treatment: Insulin</a>
              </h3>
            </header>
            <div class='body'>
              <ol type="a">
                <li> Simplest Insulin regimen - split mixed regimen ‚Äì short + intermediate (regular & NPH). Disadvantage - restriction to specific routine & meals.</li>
                <li> Frequent injection of short-acting Insulin - mimics endogenous Insulin secretion. Advantage - more flexibility & improved metabolic control.</li>
                <li> Lispro injection ‚Äì used before each meal + longer-acting Insulin more sophisticated.</li>
                <li> Insulin pump (CSII) - increasingly popular ‚Äì external device - continuous infusion through silicone tubing. Delivers preset amount titrated boluses to meal.</li>
                <li>Whichever regimen must match lifestyle of child & family.</li>
              </ol>
              
              <ol>
                <li><strong>Short-acting</strong></li>
                <ul>
                  <li>Regular/semilente ‚Äì onset - 30mins, peak - 2-4hrs, duration ‚Äì 4-6hrs</li>
                </ul>
                <li><strong>Intermediate-acting</strong></li>
                <ul>
                  <li>NPH (pork)</li>
                  <li>NPH (human) - onset - 2-4hrs, peak - 6-12hrs, duration - 10-20hrs</li>
                  <li>Lente</li>
                </ul>
                <li><strong>Long-acting</strong></li>
                <ul>
                  <li>Ultralente - onset - 12-18hrs, duration - 18-20hrs</li>
                </ul>
              </ol>
              
              <p>Split-mixed: regular + intermediate 2x/day</p>
              <ul>
                <li>2/3 before breakfast</li>
                <li>1/3 before supper</li>
                <li>1/3 regular + 2/3 NPH</li>
                <li>1/2 regular + 1/2 NPH</li>
              </ul>
              

            </div>
          </section>

          <section id='heading-7-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-7-3'>Metabolic Response</a>
              </h3>
            </header>
            <div class='body'>
              <ul>
                <li><strong>Dawn phenomenon</strong> - normal physiology due to overnight GH secretion & increased Insulin clearance.</li>
                <li>In T1DM - no compensation with increased insulin output ‚Üí increased early morning glucose levels. Usually recurrent.</li>
                <li><strong>Somogyi</strong> - High morning glucose due to a rebound from late night or early morning hypoglycemia ‚Üí exaggerated counter regulatory response. (hypoglycemia begetting hyperglycemia). But most children remain hypoglycemic. Hence rare in children.</li>
                <li><strong>Brittle diabetes</strong> - wide fluctuations in BG despite large & frequent adjustment of insulin doses. Recurrent DKA. Usually adolescent female. May be due to psychological problems, eating disorders.</li>
                <li><strong>Honeymoon phase</strong> - A transient decrease in insulin requirement associated with improved residual Œ≤ cell function. (Thought to be due to Islet cell regeneration).</li>
                <li>Younger children have no or limited H phase. Older children & adolescents - longer.</li>
              </ul>
              

            </div>
          </section>
          
        </div>
      </section>






      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
